Laurence Reilly
Direktor/Vorstandsmitglied bei IMMUPHARMA PLC
Profil
Laurence Reilly is currently a Senior Independent Non-Executive Director at ImmuPharma Plc and a Vice President-Research & Investments at Royalty Pharma Plc.
He previously worked as the Chief Scientific Officer & Vice President at Avillion LLP and as the Chief Medical Officer at Cellectar Biosciences, Inc. Reilly holds a doctorate degree from The University of Liverpool and a graduate degree from De Montfort University.
Aktive Positionen von Laurence Reilly
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUPHARMA PLC | Direktor/Vorstandsmitglied | 11.08.2023 |
| ROYALTY PHARMA PLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Laurence Reilly
| Unternehmen | Position | Ende |
|---|---|---|
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
| CELLECTAR BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Laurence Reilly
| De Montfort University | Graduate Degree |
| The University of Liverpool | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| IMMUPHARMA PLC | Health Technology |
| ROYALTY PHARMA PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
